Niraparib Maintenance in HRD-Positive Advanced Ovarian Cancer Following Front-Line Chemotherapy + Bevacizumab
Conditions: Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma Interventions: Drug: Niraparib Sponsors: Peking University Cancer Hospital& Institute Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Avastin | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Fallopian Tube Cancer | Hospitals | Ovarian Cancer | Ovaries | Research